UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 88

Sortiert nach

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

Arthritis research & therapy, 2013-01, Vol.15 (6), p.R207-R207

2013

Volltextzugriff (PDF)

Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function

Nature (London), 1999-10, Vol.401 (6755), p.808-811

1999

Volltextzugriff (PDF)

Nanobodies – from llamas to therapeutic proteins

Drug discovery today. Technologies, 2010, Vol.7 (2), p.e139-e146

2010

Volltextzugriff (PDF)

E-selectin up-regulation allows for targeted drug delivery in prostate cancer

Cancer research (Chicago, Ill.), 2003-10, Vol.63 (19), p.6387-6394

2003

Volltextzugriff (PDF)

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model

Journal of neuroimmunology, 2009-07, Vol.212 (1), p.65-73

2009

Volltextzugriff (PDF)

Anti-CSl humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Blood, 2008-08, Vol.112 (4), p.1329-1337

2008

Volltextzugriff (PDF)

Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor

Nature (London), 1990-06, Vol.345 (6278), p.810-813

1990

Volltextzugriff (PDF)

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Molecular cancer therapeutics, 2004-08, Vol.3 (8), p.921-932

2004

Volltextzugriff (PDF)

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Blood, 2008-08, Vol.112 (4), p.1329-1337

2008

Volltextzugriff (PDF)

Abstract 586: Discovery of a novel TIM3 binding partner and a key role for TIM3 on macrophages: Identification of specific antibodies capable of converting immune-suppressive macrophages to immune-enhancing

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.586-586

2016

Volltextzugriff (PDF)

Tyrosine Phosphorylation of the β3 Cytoplasmic Domain Mediates Integrin-Cytoskeletal Interactions

The Journal of biological chemistry, 1998-05, Vol.273 (22), p.13878-13885

1998

Volltextzugriff (PDF)

Signal transduction pathways for mouse platelet membrane adhesion receptors

Thrombosis and haemostasis, 1999-08, Vol.82 (2), p.345

1999

Volltextzugriff (PDF)

Tyrosine Phosphatases and the Antibody Response

Science (American Association for the Advancement of Science), 1995-04, Vol.268 (5208), p.263-264

1995

Volltextzugriff (PDF)

A Consideration of the Retention Ratio and the Impact on Selected Management and Investment Performance Metrics

Law, Debbie

2009

Volltextzugriff (PDF)

Outside-in Integrin Signal Transduction

The Journal of biological chemistry, 1996-05, Vol.271 (18), p.10811-10815

1996

Volltextzugriff (PDF)

Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies

Blood, 2006-11, Vol.108 (11), p.3503-3503

2006

Volltextzugriff (PDF)

Sa.3. Efficacy of an Anti-Mouse Cd3 Fc Modified Antibody On Experimental Autoimmune Encephalomyelitis(EAE)

Clinical immunology (Orlando, Fla.), 2006, Vol.119, p.S106-S106

2006

Volltextzugriff (PDF)

Sa.138. Characterization of An Fc Modified Anti-Mouse CD3 Antibody in a Murine Inflammatory Bowel Disease (IBD) Model

Clinical immunology (Orlando, Fla.), 2006, Vol.119, p.S154-S154

2006

Volltextzugriff (PDF)

B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn

Current biology, 1993-10, Vol.3 (10), p.645-657

1993

Volltextzugriff (PDF)

Identification of Shc as the Primary Protein Binding to the Tyrosine-phosphorylated β3 Subunit of αIIbβ3 during Outside-in Integrin Platelet Signaling

The Journal of biological chemistry, 2000-11, Vol.275 (46), p.36423-36429

2000

Volltextzugriff (PDF)

Beyond organisational design: moving from structure to service enhancement

Australian health review, 2003-01, Vol.26 (1), p.175-185

2003

Volltextzugriff (PDF)

Integrin cytoplasmic tyrosine motif is required for outside-in alpha-llb-beta-3 signalling and platelet function

Nature (London), 1999-10, Vol.401 (6755), p.808-811

1999

Volltextzugriff (PDF)

Integrin cytoplasmic tyrosine motif is required for outside-in [alpha]IIb[beta]3 signalling and platelet function

Nature (London), 1999-10, Vol.401 (6755), p.808-811

1999

Volltextzugriff (PDF)

Bursting Balls

Physiotherapy, 1989, Vol.75 (12), p.708-708

Law, Debbie

1989

Volltextzugriff (PDF)

Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent

Journal of experimental therapeutics & oncology, 2006, Vol.5 (4), p.273

2006

Volltextzugriff (PDF)

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(88)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(42)
Humans
(36)
Male
(22)
Female
(20)
Animals
(17)
Adult
(12)
Biological And Medical Sciences
(12)
Mice
(12)
Middle Aged
(8)
Public, Environmental & Occupational Health
(8)
Adolescent
(7)
Fundamental And Applied Biological Sciences. Psychology
(7)
Infectious Diseases
(7)
Oncology
(6)
Public Health
(6)
Risk Factors
(6)
Treatment Outcome
(6)
Aged
(5)
Amino Acid Sequence
(5)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis

Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function

Nanobodies – from llamas to therapeutic proteins

E-selectin up-regulation allows for targeted drug delivery in prostate cancer

Dissociation of efficacy and cytokine release mediated by an Fc-modified anti-CD3 mAb in a chronic experimental autoimmune encephalomyelitis model

Anti-CSl humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Stimulation of protein tyrosine phosphorylation by the B-lymphocyte antigen receptor

Preclinical validation of anti-TMEFF2-auristatin E–conjugated antibodies in the treatment of prostate cancer

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Abstract 586: Discovery of a novel TIM3 binding partner and a key role for TIM3 on macrophages: Identification of specific antibodies capable of converting immune-suppressive macrophages to immune-enhancing

Tyrosine Phosphorylation of the β3 Cytoplasmic Domain Mediates Integrin-Cytoskeletal Interactions

Signal transduction pathways for mouse platelet membrane adhesion receptors

Tyrosine Phosphatases and the Antibody Response

A Consideration of the Retention Ratio and the Impact on Selected Management and Investment Performance Metrics

Outside-in Integrin Signal Transduction

Eradication of Tumors in Pre-Clinical Models of Multiple Myeloma by Anti-CS1 Monoclonal Antibody HuLuc63: Mechanism of Action Studies

Sa.3. Efficacy of an Anti-Mouse Cd3 Fc Modified Antibody On Experimental Autoimmune Encephalomyelitis(EAE)

Sa.138. Characterization of An Fc Modified Anti-Mouse CD3 Antibody in a Murine Inflammatory Bowel Disease (IBD) Model

B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn

Identification of Shc as the Primary Protein Binding to the Tyrosine-phosphorylated β3 Subunit of αIIbβ3 during Outside-in Integrin Platelet Signaling

Beyond organisational design: moving from structure to service enhancement

Integrin cytoplasmic tyrosine motif is required for outside-in alpha-llb-beta-3 signalling and platelet function

Integrin cytoplasmic tyrosine motif is required for outside-in [alpha]IIb[beta]3 signalling and platelet function

Bursting Balls

Preclinical evaluation of an anti-alpha5beta1 integrin antibody as a novel anti-angiogenic agent

Suchergebnisse filtern